References
- Brandtzaeg P, Pabst R. Let's go mucosal: communication on slippery ground. Trends Immunol 2004;25:570–7.
- Harandi AM, Medaglini D. Mucosal adjuvants. Curr HIV Res 2010;8:1–6.
- Chen W, Patel GB, Yan H, Zhang J. Recent advances in the development of novel mucosal adjuvants and antigen delivery systems. Hum Vaccin 2010;6:706–14.
- Gonzalez-Fernandez A, Faro J, Fernandez C. Immune responses to polysaccharides: lessons from humans and mice. Vaccine 2008;26:292–300.
- Harrison L, Mohan N, Kirkpatrick P. Meningococcal group A, C, Y, and W135 conjugate vaccine. Nature Rev 2010;9:429–30.
- Perez O, Lastre M, Cabrera O, del Campo J, Bracho G, Cuello M, . New vaccines require potent adjuvants like AFPL1 and AFCo1. Scand J Immunol 2007;66:271–7.
- del Campo J, Zayas C, Romeu B, Acevedo R, González E, Bracho G, . Mucosal immunization using proteoliposome and cochleate structures from Neisseria meningitidis serogroup B induce mucosal and systemic responses. Methods 2009;49:301–8.
- del Campo J, Lindqvist M, Cuello M, Bäckström M, Cabrerra O, Persson J, . Intranasal immunization with a proteoliposome-derived cochleate containing recombinant gD protein confers protective immunity against genital herpes in mice. Vaccine 2010;28:1193–200.
- Cuello M, Cabrera O, Martinez I, Del Campo J, Camaraza M, Sotolongo F, . New meningococcal C polysaccharide–tetanus toxoid conjugate physico-chemical and immunological characterization. Vaccine 2007;25:1798–805.
- Zhang Q, Choo S, Everard J, Jennings R, Finn A. Mucosal immune responses to meningococcal group C conjugate and group A and C polysaccharide vaccines in adolescents. Infect Immun 2000;68:2692–7.
- Cuello M, Cabrera O, del Campo J, Parajón E, Sotolongo F, Camaraza M, . Mucosal immune responses to meningococcal C polysaccharide–protein conjugate in mice. Vaccine 2006;24:S72–3.
- Fernandez C, Moller G. Serum antibody and cellular immune response in mice to dextran B512. Cell Immunol 1990;131: 41–51.
- Rubinstein L, García-Ojeda P, Michon F, Jennings H, Stein K. Murine immune responses to Neisseria meningitidis group C capsular polysaccharide and a thymus-dependent toxoid conjugate vaccine. Infect Immun 1998;66:5450–6.
- Stein KE. Thymus-independent and thymus-dependent responses to polysaccharide antigens. J Infect Dis 1992;165: S49–52.
- Chu R, McCool T, Greenspan N, Schereiber J, Harding C. CpG oligodeoxynucleotides act as adjuvants for pneumococcal polysaccharide-protein conjugate vaccines and enhance antipolysaccharide immunoglobulin G2a (IgG2a) and IgG3 antibodies. Infect Immun 2000;68:1450–6.